University of Texas Texas AM Investment Management Co. acquired a new position in Agilent Technologies, Inc. (NYSE:A – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 8,758 shares of the medical research company’s stock, valued at approximately $1,509,000.
Several other institutional investors have also recently made changes to their positions in the business. Investment Research Partners LLC boosted its holdings in shares of Agilent Technologies by 1.8% in the third quarter. Investment Research Partners LLC now owns 3,646 shares of the medical research company’s stock worth $628,000 after buying an additional 63 shares during the last quarter. Greenleaf Trust grew its position in Agilent Technologies by 0.8% during the second quarter. Greenleaf Trust now owns 8,117 shares of the medical research company’s stock valued at $1,078,000 after buying an additional 68 shares during the period. Plan A Wealth LLC increased its holdings in Agilent Technologies by 1.9% during the third quarter. Plan A Wealth LLC now owns 3,567 shares of the medical research company’s stock valued at $615,000 after buying an additional 68 shares during the last quarter. Nilsine Partners LLC increased its holdings in Agilent Technologies by 0.8% during the second quarter. Nilsine Partners LLC now owns 9,650 shares of the medical research company’s stock valued at $1,282,000 after buying an additional 72 shares during the last quarter. Finally, Aspiriant LLC increased its holdings in Agilent Technologies by 2.0% during the third quarter. Aspiriant LLC now owns 3,786 shares of the medical research company’s stock valued at $652,000 after buying an additional 73 shares during the last quarter. Institutional investors own 87.41% of the company’s stock.
Agilent Technologies Trading Up 0.0%
Agilent Technologies stock opened at $174.79 on Monday. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $182.99. The firm has a market capitalization of $49.28 billion, a price-to-earnings ratio of 34.41, a P/E/G ratio of 2.56 and a beta of 1.24. The firm has a 50 day moving average of $165.94 and a 200 day moving average of $137.20. The company has a current ratio of 2.05, a quick ratio of 1.56 and a debt-to-equity ratio of 0.50.
Agilent Technologies (NYSE:A – Get Free Report) last issued its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The business had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.84 billion. During the same quarter in the previous year, the firm earned $1.37 earnings per share. The company’s revenue for the quarter was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, research analysts predict that Agilent Technologies, Inc. will post 6.20 earnings per share for the current year.
Agilent Technologies Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 28th. Stockholders of record on Tuesday, October 6th were given a dividend of $0.2550 per share. This represents a $1.02 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Tuesday, October 6th. Agilent Technologies’s dividend payout ratio (DPR) is presently 20.08%.
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on A shares. Bank of America increased their price target on shares of Agilent Technologies from $180.00 to $190.00 in a research report on Friday, October 9th. The Goldman Sachs Group boosted their price objective on shares of Agilent Technologies from $175.00 to $185.00 and gave the company a “buy” rating in a research report on Monday, September 21st. Rothschild & Co Redburn upped their price objective on Agilent Technologies from $160.00 to $180.00 and gave the stock a “buy” rating in a research note on Thursday, August 27th. Deutsche Bank Aktiengesellschaft assumed coverage on Agilent Technologies in a report on Monday, October 26th. They issued a “buy” rating and a $190.00 target price on the stock. Finally, Stifel Nicolaus lifted their target price on Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research report on Thursday, August 27th. Eighteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $181.45.
View Our Latest Research Report on Agilent Technologies
Insider Activity at Agilent Technologies
In related news, Director Mikael Dolsten sold 634 shares of Agilent Technologies stock in a transaction on Friday, September 4th. The shares were sold at an average price of $151.38, for a total transaction of $95,974.92. Following the transaction, the director owned 4,924 shares in the company, valued at approximately $745,395.12. The trade was a 11.41% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.17% of the stock is owned by insiders.
Agilent Technologies Company Profile
Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research.
The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.
Agilent became an independent company in 1999 through a spin-off from Hewlett-Packard.
See Also
- Five stocks we like better than Agilent Technologies
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
- Anthropic’s S-1 Strengthens the Case for Broadcom’s AI Growth
- After the Midterms, Which of These 3 Defense ETFs Looks Strongest?
- The Ugly Truth Behind SoundHound’s Q3 Results
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
